FcR-mediated enhancement of HIV-1 infection by antibody
- PMID: 2223246
- DOI: 10.1089/aid.1990.6.999
FcR-mediated enhancement of HIV-1 infection by antibody
Abstract
Although CD4 is a major receptor for human immunodeficiency virus (HIV) infection of cells, studied by ourselves and others clearly show that the Fc receptor (FcR) also plays a role in infection, perhaps in conjunction with other surface receptors. IgG antibodies to HIV-1 will enhance infectivity in cells (such as monocyte-macrophages) that have surface Fc receptors; F(ab')2 fragments of antibodies did not enhance, and blocking of FcR inhibited enhancement. The high-affinity FcR for IgG (Fc gamma RI) appeared to be functional. Sera from HIV-1-infected patients had neutralizing activity at high concentrations, but enhanced infection at low concentrations (i.e., high dilutions). Our studies show that the CD4 receptor is required for antibody-mediated enhancement of infection, as enhancement can be blocked by recombinant soluble CD4 and by Leu3 antibody. Although enhancement can be demonstrated in vitro, the in vivo importance of enhancing antibodies remains to be defined in HIV-1 infection.
Similar articles
-
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.Science. 1988 Oct 28;242(4878):580-3. doi: 10.1126/science.2972065. Science. 1988. PMID: 2972065
-
Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including the Fc gamma R.Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9593-7. doi: 10.1073/pnas.88.21.9593. Proc Natl Acad Sci U S A. 1991. PMID: 1835086 Free PMC article.
-
Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro.Scand J Immunol. 1989 Oct;30(4):425-34. doi: 10.1111/j.1365-3083.1989.tb02446.x. Scand J Immunol. 1989. PMID: 2554488
-
HIV infection and the immune system.Biochim Biophys Acta. 1989 Dec 27;989(3):255-68. Biochim Biophys Acta. 1989. PMID: 2695169 Review. No abstract available.
-
Fc Receptors in Antimicrobial Protection.Curr Top Microbiol Immunol. 2019;423:119-150. doi: 10.1007/82_2019_154. Curr Top Microbiol Immunol. 2019. PMID: 30790076 Review.
Cited by
-
Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis.Infect Immun. 1993 Feb;61(2):498-503. doi: 10.1128/iai.61.2.498-503.1993. Infect Immun. 1993. PMID: 8423079 Free PMC article.
-
Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.Front Immunol. 2017 Nov 28;8:1655. doi: 10.3389/fimmu.2017.01655. eCollection 2017. Front Immunol. 2017. PMID: 29234320 Free PMC article. Review.
-
Relationship between Vaccine-Induced Antibody Capture of Infectious Virus and Infection Outcomes following Repeated Low-Dose Rectal Challenges with Simian Immunodeficiency Virus SIVmac251.J Virol. 2016 Sep 12;90(19):8487-95. doi: 10.1128/JVI.00812-16. Print 2016 Oct 1. J Virol. 2016. PMID: 27440881 Free PMC article.
-
V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1.Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11518-22. doi: 10.1073/pnas.90.24.11518. Proc Natl Acad Sci U S A. 1993. PMID: 7505441 Free PMC article.
-
Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus.J Virol. 1992 Nov;66(11):6695-705. doi: 10.1128/JVI.66.11.6695-6705.1992. J Virol. 1992. PMID: 1383568 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials